These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 6703920

  • 1. Surgical use of fluosol-DA in Jehovah's Witness patients.
    Ohyanagi H, Nakaya S, Okumura S, Saitoh Y.
    Artif Organs; 1984 Feb; 8(1):10-8. PubMed ID: 6703920
    [Abstract] [Full Text] [Related]

  • 2. Present status of clinical studies of Fluosol-DA (20%) in Japan.
    Mitsuno T, Ohyanagi H.
    Int Anesthesiol Clin; 1985 Feb; 23(1):169-84. PubMed ID: 3980104
    [Abstract] [Full Text] [Related]

  • 3. Fluosol-DA, a perfluorochemical oxygen-transport fluid for the management of a trochanteric pressure sore in a Jehovah's Witness.
    Brown AS, Reichman JH, Spence RK.
    Ann Plast Surg; 1984 May; 12(5):449-53. PubMed ID: 6742725
    [Abstract] [Full Text] [Related]

  • 4. U.S. clinical studies of the treatment of anemia with fluosol-DA 20%.
    Tremper KK, Cullen BF.
    Artif Organs; 1984 Feb; 8(1):19-24. PubMed ID: 6367719
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Changes of hemodynamics and O2 transport associated with the perfluorochemical blood substitute, Fluosol-DA.
    Nishimura N, Sugi T.
    Crit Care Med; 1984 Jan; 12(1):36-8. PubMed ID: 6690204
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Limitation of myocardial reperfusion injury by intravenous perfluorochemicals. Role of neutrophil activation.
    Bajaj AK, Cobb MA, Virmani R, Gay JC, Light RT, Forman MB.
    Circulation; 1989 Mar; 79(3):645-56. PubMed ID: 2537160
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Modification of cerebral ischemia with Fluosol.
    Peerless SJ, Nakamura R, Rodriguez-Salazar A, Hunter IG.
    Stroke; 1985 Mar; 16(1):38-43. PubMed ID: 3966263
    [Abstract] [Full Text] [Related]

  • 11. Effect of perfluorochemical (Fluosol-DA) on infarct morphology in dogs.
    Kolodgie FD, Dawson AK, Forman MB, Virmani R.
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1985 Mar; 50(2):119-34. PubMed ID: 2868560
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of intracoronary infusion of arterial blood or Fluosol-DA 20% on regional myocardial metabolism and function during brief coronary artery occlusions.
    Tokioka H, Miyazaki A, Fung P, Rajagopalan RE, Kar S, Meerbaum S, Corday E, Drury JK.
    Circulation; 1987 Feb; 75(2):473-81. PubMed ID: 2948736
    [Abstract] [Full Text] [Related]

  • 14. Fluosol: therapeutic failure in severe anemia.
    Kale PB, Sklar GE, Wesolowicz LA, DiLisio RE.
    Ann Pharmacother; 1993 Dec; 27(12):1452-4. PubMed ID: 8305774
    [Abstract] [Full Text] [Related]

  • 15. Fluosol-DA as a red-cell substitute in acute anemia.
    Gould SA, Rosen AL, Sehgal LR, Sehgal HL, Langdale LA, Krause LM, Rice CL, Chamberlin WH, Moss GS.
    N Engl J Med; 1986 Jun 26; 314(26):1653-6. PubMed ID: 3713771
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antipyrine kinetics following partial blood exchange with Fluosol-DA in the rat.
    Shrewsbury RP, White SG, Pollack GM, Wargin WA.
    J Pharm Pharmacol; 1986 Dec 26; 38(12):883-7. PubMed ID: 2880960
    [Abstract] [Full Text] [Related]

  • 18. Clinical experience with Fluosol-DA (20%) in the United States.
    Tremper KK, Levine EM, Waxman K.
    Int Anesthesiol Clin; 1985 Dec 26; 23(1):185-97. PubMed ID: 3884514
    [No Abstract] [Full Text] [Related]

  • 19. Effects of a transfusion with a blood substitute (Fluosol-DA, 20%) on cerebral circulation in the monkey.
    Nagasawa S, Handa H, Naruo Y, Oda Y, Yonekawa Y, Takebe Y.
    Neurol Res; 1981 Dec 26; 3(3):237-50. PubMed ID: 6122175
    [Abstract] [Full Text] [Related]

  • 20. Effect of a perfluorocarbon emulsion (Fluosol-DA) on reticuloendothelial system clearance function.
    Castro O, Nesbitt AE, Lyles D.
    Am J Hematol; 1984 Jan 26; 16(1):15-21. PubMed ID: 6695906
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.